We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events (EKVASIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01770210
Recruitment Status : Completed
First Posted : January 17, 2013
Last Update Posted : August 19, 2014
Information provided by (Responsible Party):
Elpen Pharmaceutical Co. Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2014
  Study Completion Date : July 2014